Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.43
Delayed Data
As of Sep 27
 +0.0127 / +3.04%
Today’s Change
0.29
Today|||52-Week Range
1.33
-63.25%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.42
Today’s open0.45
Day’s range0.42 - 0.52
Volume8,118,937
Average volume (3 months)1,470,305
Market cap$101.1M
Dividend yield--
Data as of 09/27/2016

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+66.86%
P/E ratioNM
Price/Sales1.71
Price/Book1.97

Competitors

 Today’s
change
Today’s
% change
ORMPOramed Pharmaceutica...-0.07-0.90%
SBPHSpring Bank Pharmace...-1.07-8.25%
ALIMAlimera Sciences Inc-0.01-0.32%
GEMPGemphire Therapeutic...+0.11+0.97%
Data as of 09/27/2016

Financials

Next reporting dateDecember 12, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$44.7M
Annual profit (last year)-$55.7M
Net profit margin-124.54%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts

Search for Jobs